S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
66,000% upside on tiny biotech? (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
66,000% upside on tiny biotech? (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
The Trade Desk: 3 reasons to buy before a new all-time high
Laser breakthrough could send stock soaring 2,467% (Ad)
Rivian shares gets discounted; shares can move lower 
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
66,000% upside on tiny biotech? (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
66,000% upside on tiny biotech? (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
The Trade Desk: 3 reasons to buy before a new all-time high
Laser breakthrough could send stock soaring 2,467% (Ad)
Rivian shares gets discounted; shares can move lower 
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
66,000% upside on tiny biotech? (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
66,000% upside on tiny biotech? (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
The Trade Desk: 3 reasons to buy before a new all-time high
Laser breakthrough could send stock soaring 2,467% (Ad)
Rivian shares gets discounted; shares can move lower 
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard
S&P 500   5,087.03
DOW   39,069.11
QQQ   438.07
Top-Rated AMD nears major breakout level
66,000% upside on tiny biotech? (Ad)
Roku stock and the mother of all entry opportunities
AI powerhouse NVIDIA will hit $1000 soon
66,000% upside on tiny biotech? (Ad)
Nvidia, Royal Caribbean rise; Rivian, Etsy fall, Thursday, 2/22/2024
The Trade Desk: 3 reasons to buy before a new all-time high
Laser breakthrough could send stock soaring 2,467% (Ad)
Rivian shares gets discounted; shares can move lower 
Wall Street sees a solid year ahead for homebuilders, though mortgage rates remain a wildcard

Neurocrine Biosciences (NBIX) Earnings Date, Estimates & Call Transcripts

$133.37
+2.72 (+2.08%)
(As of 02/22/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 1Estimated
Actual EPS
(Feb. 7)
$1.44 Beat By $0.31
Consensus EPS
(Feb. 7)
$1.13
Skip Charts & View Estimated and Actual Earnings Data

NBIX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NBIX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Neurocrine Biosciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20243$0.94$1.09$1.02 
Q2 20244$1.14$1.27$1.20 
Q3 20244$1.18$1.49$1.38 
Q4 20243$1.43$1.96$1.65 
FY 202414$4.69$5.81 $5.25

NBIX Earnings Date and Information

Neurocrine Biosciences last issued its quarterly earnings results on February 7th, 2024. The reported $1.44 EPS for the quarter, beating the consensus estimate of $1.13 by $0.31. The firm earned $515.20 million during the quarter, compared to the consensus estimate of $518.52 million. Its revenue was up 25.0% compared to the same quarter last year. Neurocrine Biosciences has generated $2.42 earnings per share over the last year ($2.42 diluted earnings per share) and currently has a price-to-earnings ratio of 55.1. Earnings for Neurocrine Biosciences are expected to grow by 27.98% in the coming year, from $4.86 to $6.22 per share. Neurocrine Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off prior year's report dates.

Neurocrine Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/1/2024
Estimated)
------- 
2/7/2024Q4 2023$1.13$1.44+$0.31$1.44$518.52 million$515.20 million      
10/31/2023Q3 2023$0.91$0.82($0.09)$0.82$479.09 million$498.80 million      
8/1/2023Q2 2023$0.77$0.95+$0.18$0.95$448.29 million$452.70 million
5/3/2023Q1 2023$0.26($0.79)($1.05)($0.79)$412.96 million$420.40 million
2/6/2023Q4 2022$1.15$1.24+$0.09$0.88$408.96 million$412.00 million    
11/1/2022Q3 2022$0.84$0.69($0.15)$0.69$378.05 million$387.90 million
8/4/2022Q2 2022$0.56($0.18)($0.74)($0.18)$340.62 million$378.20 million
5/4/2022Q1 2022$0.33$0.14($0.19)$0.14$304.07 million$310.60 million      
2/11/2022Q4 2021$0.61($0.08)($0.69)($0.08)$317.72 million$312.00 million    
11/1/2021Q3 2021$0.51$0.23($0.28)$0.23$297.02 million$296.00 million    
8/2/2021Q2 2021$0.52$0.43($0.09)$0.43$274.47 million$288.90 million    
5/4/2021Q1 2021$0.47$0.33($0.14)$0.33$247.81 million$236.60 million    












Neurocrine Biosciences Earnings - Frequently Asked Questions

When is Neurocrine Biosciences's earnings date?

Neurocrine Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 1st, 2024 based off last year's report dates. Learn more on NBIX's earnings history.

Did Neurocrine Biosciences beat their earnings estimates last quarter?

In the previous quarter, Neurocrine Biosciences (NASDAQ:NBIX) reported $1.44 earnings per share (EPS) to beat the analysts' consensus estimate of $1.13 by $0.31. Learn more on analysts' earnings estimate vs. NBIX's actual earnings.

How can I listen to Neurocrine Biosciences's earnings conference call?

The conference call for Neurocrine Biosciences's latest earnings report can be listened to online. Listen to Conference Call

How can I read Neurocrine Biosciences's conference call transcript?

The conference call transcript for Neurocrine Biosciences's latest earnings report can be read online. Read Transcript

How can I view Neurocrine Biosciences's earnings report?

Neurocrine Biosciences's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does Neurocrine Biosciences generate each year?

Neurocrine Biosciences (NASDAQ:NBIX) has a recorded annual revenue of $1.89 billion.

How much profit does Neurocrine Biosciences generate each year?

Neurocrine Biosciences (NASDAQ:NBIX) has a recorded net income of $249.70 million. NBIX has generated $2.42 earnings per share over the last four quarters.

What is Neurocrine Biosciences's price-to-earnings ratio?

Neurocrine Biosciences (NASDAQ:NBIX) has a trailing price-to-earnings ratio of 55.11 and a forward price-to-earnings ratio of 27.44. The price/earnings-to-growth ratio is 0.84.

What is Neurocrine Biosciences's EPS forecast for next year?

Neurocrine Biosciences's earnings are expected to grow from $4.86 per share to $6.22 per share in the next year, which is a 27.98% increase.


More Earnings Resources from MarketBeat

This page (NASDAQ:NBIX) was last updated on 2/23/2024 by MarketBeat.com Staff